Pioglitazone Synthetic Analogue Ameliorates Streptozotocin-Induced Diabetes Mellitus through Modulation of ACE 2/Angiotensin 1–7 via PI3K/AKT/mTOR Signaling Pathway

Pioglitazone Synthetic Analogue Ameliorates Streptozotocin-Induced Diabetes Mellitus through Modulation of ACE 2/Angiotensin 1–7 via PI3K/AKT/mTOR Signaling Pathway

The renin angiotensin aldosterone system has a localized key regulatory action, especially in liver and body circulation. Furthermore, it accomplishes a significant role in the downregulation of the PI3K/AKT/mTOR signaling pathway that is involved in type II diabetes mellitus pathogenesis. The curre...

Full description

Bibliographic Details
Main Authors:	Yasmin M. Ahmed, Mohamed A. Abdelgawad, Khaled Shalaby, Mohammed M. Ghoneim, Asmaa M. AboulMagd, Nada S. Abdelwahab, Hossam M. Hassan, Asmaa M. Othman
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Series:	Pharmaceuticals
Subjects:	angiotensin-converting enzyme 2 (ACE 2) angiotensin 1–7 liver insulin sensitivity type 2 diabetes mellitus phosphoinositide 3-kinases (PI3k)
Online Access:	https://www.mdpi.com/1424-8247/15/3/341

Similar Items

Thymosin-α1 binds with ACE and downregulates the expression of ACE2 in human respiratory epithelia
by: Yu-Hang Zhang, et al.
Published: (2022-02-01)

Age-related reduction in brain ACE-2 is not exacerbated by Alzheimer’s disease pathology in mouse models of Alzheimer’s disease
by: Robert MacLachlan, et al.
Published: (2023-01-01)

Vitamin D improves hepatic alterations in ACE1 and ACE2 expression in experimentally induced metabolic syndrome
by: Sara Mohater, et al.
Published: (2023-09-01)

Circulating Soluble ACE2 Plays an Independent Role to Protect against Vascular Damage in Diabetic Mice
by: Chris Tikellis, et al.
Published: (2022-05-01)

Angiotensin Converting Enzyme 2 (ACE2) in Pregnancy: Preeclampsia and Small for Gestational Age
by: Sonia Tamanna, et al.
Published: (2020-09-01)

Corrigendum: Angiotensin Converting Enzyme 2 (ACE2) in Pregnancy: Preeclampsia and Small for Gestational Age
by: Sonia Tamanna, et al.
Published: (2021-05-01)

ACE2, the Counter-Regulatory Renin–Angiotensin System Axis and COVID-19 Severity
by: Filippos Triposkiadis, et al.
Published: (2021-08-01)

The ACE2/Angiotensin-(1–7)/Mas Receptor Axis: Pleiotropic Roles in Cancer
by: Juanjuan Xu, et al.
Published: (2017-05-01)

The Use of ACE inhibitor/ARB in SARS-CoV-2 Patients: A Comprehensive Narrative Review
by: Timotius Ivan Hariyanto, et al.
Published: (2020-11-01)

Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients
by: Ikram Omar Osman, et al.
Published: (2021-06-01)

Update on the Angiotensin Converting Enzyme 2-Angiotensin (1-7)-Mas Receptor Axis: Fetal Programming, Sex Differences and Intracellular Pathways
by: Mark C. Chappell, et al.
Published: (2014-01-01)

Treatment and Management of Hypertension by Targeting ACE Inhibitors: in silico Approach
by: Seema Bawa, et al.
Published: (2019-03-01)

Calcium Signaling Pathway Is Involved in the Shedding of ACE2 Catalytic Ectodomain: New Insights for Clinical and Therapeutic Applications of ACE2 for COVID-19
by: Artemio García-Escobar, et al.
Published: (2022-01-01)

Should we use angiotensin II infusion in COVID-19-associated vasoplegic shock?
by: Karim Bendjelid
Published: (2020-07-01)

Synthesis of angiotensin-converting enzyme (ACE) inhibitors: an important class of antihypertensive drugs
by: Lima Dênis Pires de
Published: (1999-01-01)

Children With Short Stature Display Reduced ACE2 Expression in Peripheral Blood Mononuclear Cells
by: Federica Tonon, et al.
Published: (2022-07-01)

ACE inhibitor angioedema: characterization and treatment versus non-ACE angioedema in acute hospitalized patients
by: David S. Weisman, et al.
Published: (2020-01-01)

Angiotensin-Converting Enzyme 2 (ACE2) as a Potential Diagnostic and Prognostic Biomarker for Chronic Inflammatory Lung Diseases
by: Dejan Marčetić, et al.
Published: (2021-07-01)

Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor
by: Tümay Capraz, et al.
Published: (2021-12-01)

Biological sex differences in renin angiotensin system enzymes ACE and ACE2 regulate normal tissue response to radiation injury
by: Guru Prasad Sharma, et al.
Published: (2023-05-01)

Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors
by: Daniel eClayton, et al.
Published: (2015-01-01)

The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains
by: Rongrong Chen, et al.
Published: (2021-01-01)

The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19
by: Mira Bosso, et al.
Published: (2020-09-01)

Lemon Extract Reduces Angiotensin Converting Enzyme (ACE) Expression and Activity and Increases Insulin Sensitivity and Lipolysis in Mouse Adipocytes
by: Shilpa Tejpal, et al.
Published: (2020-08-01)

Role of ACE 2 and Vitamin D: The Two Players in Global Fight against COVID-19 Pandemic
by: Tapan Behl, et al.
Published: (2021-06-01)

ACE2 as a Therapeutic Target for COVID-19; Its Role in Infectious Processes and Regulation by Modulators of the RAAS System
by: Veronique Michaud, et al.
Published: (2020-07-01)

The Role of ACE, ACE2, and AGTR2 Polymorphisms in COVID-19 Severity and the Presence of COVID-19-Related Retinopathy
by: Kristina Jevnikar, et al.
Published: (2022-06-01)

The Role of Glutathione in Protecting against the Severe Inflammatory Response Triggered by COVID-19
by: Francesca Silvagno, et al.
Published: (2020-07-01)

Characterization of ACE2 naturally occurring missense variants: impact on subcellular localization and trafficking
by: Sally Badawi, et al.
Published: (2022-09-01)

Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system
by: Michal Herman-Edelstein, et al.
Published: (2021-04-01)

From gene to protein - experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension
by: Sheila K Patel, et al.
Published: (2014-06-01)

Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19
by: Keiji Kuba, et al.
Published: (2021-12-01)

Renin Angiotensin System Blockers and Risk of Mortality in Hypertensive Patients Hospitalized for COVID-19: An Italian Registry
by: Fabio Angeli, et al.
Published: (2022-01-01)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
by: Carlos P. Vio, et al.
Published: (2020-06-01)

Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer’s Disease
by: Qiyue Ding, et al.
Published: (2021-02-01)

ACE2 pathway regulates thermogenesis and energy metabolism
by: Xi Cao, et al.
Published: (2022-01-01)

Effects of Angiotensin II Type 1A Receptor on ACE2, Neprilysin and KIM-1 in Two Kidney One Clip (2K1C) Model of Renovascular Hypertension
by: Laale F. Alawi, et al.
Published: (2021-01-01)

Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
by: Enrique Ambrocio-Ortiz, et al.
Published: (2021-08-01)

Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection
by: S. Seltzer
Published: (2020-12-01)

Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
by: Oghenemega Okoloko, et al.
Published: (2021-11-01)